The 2025 Novo Nordisk Foundation Challenge Programme awards DKK 479 million to nine innovative projects that advance health and sustainability through cooperation between researchers from all over the globe, including Denmark, Sweden, The Netherlands, Belgium, Germany, Australia, and the USA. Read more…
Designed proteins are anticipated to have groundbreaking impact on a range of issues from treating disease to tackling environmental problems. With a DKK 700 million grant from the Novo Nordisk Foundation and headed by Professor Dek Woolfson, a new Center for Protein Design (CPD) at the University of Copenhagen has ambitions to match this potential. […]
With the agreement, the Foundation expands its existing collaboration with WHO, committing to a granting frame of up to DKK 380 million over the next four years. At the 78th World Health Assembly in Geneva, the Novo Nordisk Foundation has pledged up to DKK 380 million to the WHO for the period 2025-2028. The Foundation […]
Copenhagen, Denmark: The Novo Nordisk Foundation today announced the latest edition of its annual Challenge Programme, where for the first time it is inviting researchers from outside Denmark, in the European Schengen area, Ireland and the UK, to lead collaborations applying for grants to study four major themes. As part of its ongoing internationalisation, the […]
Novo Holdings and the Export and Investment Fund of Denmark (EIFO) have jointly invested €48 million in HealthCap IX, a Swedish life sciences venture fund focused on building innovative companies in areas of high unmet medical need. Following the investment, HealthCap will establish a local presence in Copenhagen at the BioInnovation Institute (BII) to increase […]
